News Daily News Low US Participation in NIH-Sponsored CVD Trials Cause for Concern Jason Kahn August 01, 2011
CME Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes